Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Immunotherapy Center is a specialized medical facility located in Tijuana, Mexico, that focuses on providing advanced immunotherapy treatments for cancer and chronic degenerative diseases. The center offers a range of personalized protocols, including dendritic cell vaccines, natural killer (NK) cell therapy, and peptide-based treatments, often integrated with supportive metabolic therapies. Their approach emphasizes stimulating the patient's own immune system to recognize and eliminate malignant cells while minimizing the side effects typically associated with conventional chemotherapy and radiation. The center serves an international patient base seeking alternative or complementary oncology solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immunotherapy Center.